Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baruch Ovadia

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Endoscopy|March 18, 2024
Comparative evaluation of a language model and human specialists in the application of European guidelines for the management of inflammatory bowel diseases and malignanciesItai Ghersin, Roni Weisshof, Eduard Koifman, et al.
Gastroenterology|October 31, 2021
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFαHadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, et al.
Vaccines|March 26, 2022
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli ExperienceLev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya'acov, et al.
Vaccines|July 27, 2022
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel DiseasesKeren Masha Rabinowitz, Michal Navon, Hadar Edelman-Klapper, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Endoscopy|March 18, 2024
Comparative evaluation of a language model and human specialists in the application of European guidelines for the management of inflammatory bowel diseases and malignanciesItai Ghersin, Roni Weisshof, Eduard Koifman, et al.
Gastroenterology|October 31, 2021
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFαHadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, et al.
Vaccines|March 26, 2022
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli ExperienceLev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya'acov, et al.
Vaccines|July 27, 2022
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel DiseasesKeren Masha Rabinowitz, Michal Navon, Hadar Edelman-Klapper, et al.
Pageof 2